ArticleCureus2020

Pembrolizumab-Induced Immune-Mediated Hepatitis and Concurrent Hepatitis B Reactivation in a Patient With Non-Small Cell Lung Cancer.

Shanker Kundumadam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.